Tue, Nov. 22, 3:33 PM
- Looking at the top 50 hedge fund hotels, it's probably little surprise that Amazon (NASDAQ:AMZN) and Facebook (NASDAQ:FB) top the list, with Amazon making for a top 10 holding in 61 funds, and Facebook in 57.
- Rounding out the top 10 are Charter Communications (NASDAQ:CHTR), Alphabet (GOOG, GOOGL), Apple (NASDAQ:AAPL), Microsoft (NASDAQ:MSFT), Yahoo (NASDAQ:YHOO), Allergan (NYSE:AGN), Bank of America (NYSE:BAC), and Priceline (NASDAQ:PCLN).
- Looking at another gauge - the percent of market cap owned by hedge funds - shows CommScope (NASDAQ:COMM) leading the way, with hedge funds owning 37%. Next is Dell Technologies (NYSE:DVMT) and Expedia (NASDAQ:EXPE) at 30%, and after that: Liberty Broadband (NASDAQ:LBRDK) at 24%, LinkedIn (NYSE:LNKD) at 21%, Constellation Brands (NYSE:STZ) at 20%, and Humana (NYSE:HUM) and WhiteWave Foods (NYSE:WWAV) at 19%.
- Previously: Goldman's list of shorts mattering most to hedge funds (Nov. 22)
Mon, Nov. 21, 2:10 AM
- The stakes are high as the DOJ's antitrust case against Anthem (NYSE:ANTM) and Cigna's (NYSE:CI) merger gets underway in Washington, D.C.
- Expect more of the usual drama: The $54B tie-up is being billed as bad for consumers and both companies have accused each other of breaching their merger agreement.
- The case will be followed by a second trial involving the proposed combination of Aetna (NYSE:AET) and Humana (NYSE:HUM) on Dec. 5.
Thu, Nov. 17, 12:18 PM
- In no surprise, the list is dominated by the ripping financial sector:
- Allstate (ALL +1.4%)
- Ameriprise (AMP +0.2%)
- TD Ameritrade (AMTD +1.6%)
- BB&T (BBT +2.1%)
- Citigroup (C +2.4%)
- Citizens Financial (CFG +2%)
- Comerica (CMA +1.5%)
- CNA Financial (CNA +0.6%)
- Loews Corp. (L +0.9%)
- Marsh & McLennan (MMC +1.9%)
- PNC Financial (PNC +2.6%)
- Royal Bank of Canada (RY +0.7%)
- U.S. Bancorp (USB +1.9%)
- Aetna (AET +1.5%)
- Best Buy (BBY +10.4%)
- CBS (CBS +0.6%)
- Celanese (CE +0.1%)
- Comcast (CMCSA +1.5%)
- Dell Technologies (DVMT +1.1%)
- The Gap (GPS +0.4%)
- Humana (HUM +1.4%)
- KLA-Tencor (KLAC +2.7%)
- Liberty Media (LMCA +1.6%)
- Lam Research (LRCX +1.9%)
- Micron (MU +5.3%)
- Nvidia (NVDA +2.7%)
- Rockwell (ROK -0.5%)
- Teck Resources (TCK +0.5%)
- Texas Instruments (TXN +1.1%)
- New lows:
- Novo Nordisk (NVO +0.3%)
Mon, Nov. 14, 4:42 PM
- New positions for Greenlight Capital as of Sept. 30: U.S. Steel (NYSE:X), and GEO Group (NYSE:GEO).
- Major exits: Twenty-First Century Fox (NASDAQ:FOXA), Humana (NYSE:HUM), Perrigo (NASDAQ:PRGO), AmerisourceBergen (NYSE:ABC), Hertz (NYSE:HTZ), Community Health (NYSE:CYH), Lamar Advertising (NASDAQ:LAMR), Vodafone (NASDAQ:VOD).
Mon, Nov. 14, 3:47 PM
- Unsurprisingly given their run of late, financials dominate the list:
- Bank of America (BAC +5%)
- Citigroup (C +1.5%)
- Citizens Financial (CFG +3.1%)
- Discover (DFS +3.1%)
- First Republic (FRC +2.5%)
- Goldman Sachs (GS +2.2%)
- Humana (HUM +3%)
- Manulife (MFC +2.9%)
- Northern Trust (NTRS +3%)
- PNC Financial (PNC +1.7%)
- Regions Financial (RF +6.5%)
- Schwab (SCHW +1.6%)
Fri, Nov. 11, 12:07 PM
- Aetna (AET +0.4%) and Humana (HUM +0.4%) are upgraded to Outperform from Neutral at Credit Suisse, which says a Trump administration may improve prospects for health care stocks in general and also increase the chances that AET's pending deal to buy HUM would pass muster with antitrust officials.
- The firm also says prospects for Medicare Advantage appear “particularly bright,” while there is uncertainty around the stocks of companies that are highly leveraged to the Affordable Care Act as a driver of their growth stories, particularly hospitals and Medicaid MCOs.
- Credit Suisse raises its stock price target for AET to $135 from $120 and for HUM to $210 from $170.
Fri, Nov. 11, 6:47 AM
- Novartis (NYSE:NVS) upgraded to Buy from Hold with an $85 (15% upside) price target by Argus Research.
- Humana (NYSE:HUM) upgraded to Overweight from Neutral with a $202 (5% upside) price target by JPMorgan.
- McKesson (NYSE:MCK) upgraded to Buy from Neutral with a $147 (0% upside) price target by Mizuho Securities.
- AmerisourceBergen (NYSE:ABC) upgraded to Buy from Neutral by Mizuho Securities. Price target raised to $89 (12% upside) from $84.
- Healthways (NASDAQ:HWAY) upgraded to Buy from Sell by UBS Global Research. Price target raised to $24 (9% upside) from $22.50.
- ACADIA Pharmaceuticals (NASDAQ:ACAD) upgraded to Buy from Neutral by Bank of America. Price target lowered to $35 (22% upside) from $39.
- Biogen (NASDAQ:BIIB) upgraded to Overweight from Neutral with a $335 (3% upside) price target by Piper Jaffray.
- Juno Therapeutics (NASDAQ:JUNO) upgraded to Neutral from Sell by BTIG Research.
- Express Scripts (NASDAQ:ESRX) upgraded to Hold from Sell by Deutsche Bank. Price target increased to $70 (7% downside risk) from $69.
Wed, Nov. 9, 8:29 AM
- Hospital groups look a bit sickly premarket as investors appear to perceive a less-than-robust future under a Trump presidency.
- Sampling: (NYSE:HUM) -2%; (NYSE:HCA) -16%; (NYSE:THC) -26%; (NYSE:CYH) -18%; (NYSE:UHS) -10%; (NYSE:SEM) -7%; (NASDAQ:LPNT) -12%
- Healthcare services are weak as well: (NYSE:UNH) -3%; (NYSE:MOH) -8%; (NASDAQ:AMSG) -11%; (NASDAQ:AMED) -3%; (NYSE:EVHC) -5%
Wed, Nov. 9, 3:03 AM
- Healthcare stocks, the weakest sector this year, may become winners, as Obamacare reforms are set to be "repealed and replaced" and major legislation Clinton proposed is unlikely to be imposed on drugmakers.
- While Trump hasn't set out a comprehensive alternative to the Affordable Care Act (which may see 22M Americans lose current coverage), he said he'll encourage competition between markets in different states.
- Insurance stocks: UNH, AET, ANTM, CI, HUM, WCG, CNC, MOH, GTS, HQY
- Drugmakers premarket: MYL +5.8%, NVS +3.4%, SNY +2.9%, AZN +2.4%, GSK +1.9%, PFE +1.8%, CELG +1%, ABBV, MRK, BMY, LLY, JNJ, ABT, ACET, ZTS, BIIB, REGN
Mon, Nov. 7, 11:30 AM
- Investors are moving back into hospital groups in early trading on what appears to be a collective sigh of relief that the FBI investigation into candidate Clinton's email management while Secretary of State has been shut down. The investigative agency reiterated its statement that she is not guilty of any crime. In other words, she is "on go" to be elected President.
- Representative tickers: (HUM +3.8%)(THC +13.5%)(HCA +5%)(CYH +9.1%)(UHS +4.3%)(SEM +7.4%)(LPNT +4.8%)
Fri, Nov. 4, 6:54 AM
- Humana (HUM) Q3 results: Revenues: $13,694M (+2.5%); Operating Income: $949M (+36.5%); Net Income: $450M (+43.3%); EPS: $2.98 (+42.6%); Non-GAAP EPS: $3.18 (+41.3%); Quick Assets: $6,769M (+163.3%); CF Ops: $4,503M (+336.3%).
- 2016 Guidance: Revenues: ~$55B from at least $54B - 54.5B; EPS: ~$8.68; Non-GAAP EPS: ~$9.50.
Fri, Nov. 4, 6:06 AM
Thu, Nov. 3, 5:30 PM
Thu, Oct. 27, 3:41 AM
- Not only are Obamacare premiums on the rise for 2017, deductibles will also be getting more expensive, according to an analysis by insurance comparison site HealthPocket.
- Deductibles for individuals enrolled in the lowest-priced Obamacare health plans will average more than $6,000 next year, the first time that threshold has been cracked in the three years that Affordable Care Act marketplaces have been in business. Families enrolled in the bronze plans will average deductibles of $12,393.
- Previously: Obamacare rates up 25% in 2017 (Oct. 25 2016)
- Related tickers: UNH, AET, ANTM, CI, HUM, WCG, CNC, MOH, GTS, HQY
Wed, Oct. 26, 4:54 PM
Tue, Oct. 25, 2:22 AM
- The average premium for benchmark 2017 Obamacare insurance plans sold on Healthcare.gov will jump 25% to $302 compared to this year, the biggest increase since the insurance first went on sale in 2013.
- Seeking to downplay the cost hikes, the administration said that including subsidies 77% of people would be able to find insurance plans with monthly premiums below $100, however, one in five consumers will only have one insurer from which to choose coverage.
- Related tickers: UNH, AET, ANTM, CI, HUM, WCG, CNC, MOH, GTS, HQY